Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, WOM

Wildflower Health Receives Prestigious Industry Award During HLTH 2022 for Excellence in Women's Health, Population Health Management, Patient Engagement


Company's Groundbreaking Value-Based Maternity Care Bundle Earns Accolades from Fierce Innovation Awards

SAN FRANCISCO, Nov. 15, 2022 /PRNewswire-PRWeb/ -- Wildflower Health received a prestigious industry award during HLTH 2022 for its groundbreaking work in women's health and value-based maternity care. The Fierce Innovation Awards chose Wildflower as a category winner for the company's transformative value-based maternity care bundle.

Wildflower has architected the industry's most comprehensive bundle for value-based maternity care, with pre-built functionality for all actuarial, clinical and operational needs. This solution includes a combination of technology, health advocacy/coaching and value enablement services, all designed to simplify the journey to value-based care for providers, payers, and purchasers by collapsing silos and aligning rewards around the delivery of healthy outcomes for women and their families.

The solution helps patients actively participate in their health while equipping and empowering providers to deliver care the way they want. It specifically addresses and improves access, equity, experience and outcomes.

Based on the strength of this bundle solution, the Fierce Innovation Awards: Healthcare Edition named Wildflower the winner of its Population Health Management/Patient Engagement category, which evaluated solutions for transparency, care management, patient education and social engagement.

"Winners of the Fierce Innovation Awards represent those that champion innovation in the face of great competition," said Rebecca Willumson, SVP & Publisher of Fierce Biotech and Fierce Pharma. "Our panel of judges looked for effectiveness, technical innovation, competitive advantage, financial impact and true innovation. We are very proud of this year's class and send our congratulations to all of the Innovation Award winners."

Each year, this awards program identifies and showcases outstanding innovation that is driving improvement and transforming the industry. Winners for this year's awards were featured in a special innovations report that was released during the HLTH 2022 conference.

"We believe in our ability to bring much needed innovation to healthcare and to help transform care delivery and payment models within women's health," said Leah Sparks, founder and CEO of Wildflower Health. "We are so honored to receive such powerful validation for the work we are doing from a well-respected organization like Fierce. It's inspiring to us as we continue to work toward our mission of delivering the best care, to all women, every time."

About Wildflower
Wildflower is a technology and services company that is transforming care delivery and payment models in women's health to radically improve outcomes. We offer a modular suite of software, support and services, meeting providers and payers where they are in their journey to value. We are also the architect of the industry's most comprehensive bundle for value-based maternity care, with pre-built functionality for all actuarial, clinical and operational needs. Wildflower can help you successfully address the key drivers of women's health outcomes while building a better future for you and the families you serve. We are ushering in a new era for women's health. This is a smarter way to care. http://www.wildflowerhealth.com

Media Contact

Jessica Szalay, Wildflower Health, 408-780-8983, [email protected]

 

SOURCE Wildflower Health


These press releases may also interest you

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:00
V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology's (ACC) Annual Scientific Session & Expo taking place April 6-8 in Atlanta. RELIEVE-HF is a randomized, double-blind,...

at 12:00
Critical Path Institute's (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for...

at 11:45
SummaryProduct: Henna cones Issue: Chemical hazard / Product safety What to do: Stop using and selling them immediately and dispose of them in regular household garbage Who this is for: General public / Industry; Retail, Importers IssueHealth Canada...

at 11:30
The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 11:30
XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid...



News published on and distributed by: